In this commentary, Michael J. Bloch, MD, and Evan Bloch discuss the optimal approach to managing patients with hypertension in the United States, including using patients' self-measured blood pressure and...
In this commentary, Michael J. Bloch, MD, and Evan Bloch discuss the optimal approach to managing patients with hypertension in the United States, including using patients' self-measured blood pressure and...
In this article, Michael J. Bloch, MD, and Evan Bloch discuss the findings from the CARDIA-SSBP trial, which investigates the blood pressure responses to dietary sodium increase and decrease across a wide...
In this article, Michael J. Bloch, MD, and Evan Bloch discuss the findings from the CARDIA-SSBP trial, which investigates the blood pressure responses to dietary sodium increase and decrease across a wide...
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
In this video, Michael J. Bloch, MD, discusses hypertension and a patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO...
Previous reports have suggested that mean blood pressure (BP) increased during the early years of the COVID-19 pandemic across the United States.1 There have been many hypotheses regarding why–including...
In this video, Michael J. Bloch, MD, discusses the link between combined oral contraceptives and increased risk of arterial thrombosis, the risk of venous thromboembolic disease, and...
In this video, Michael J. Bloch, MD, discusses the use of combined oral contraceptives, which are the most common forms of birth control used by women in the United States, oral estrogen-free progestin-only...
